Crafting a Founder Agreement at HealthCraft Custom Case Solution & Analysis

1. Evidence Brief: HealthCraft Case Extraction

Source: HBS Case 813-101

Financial Metrics

• Initial Capital: David contributed 50,000 dollars in personal savings to cover initial development costs and legal filings.
• Burn Rate: Monthly expenses currently average 8,500 dollars, primarily for server costs and part-time contractor support.
• Funding Status: The team is preparing for a Seed Round target of 1.5 million dollars but lacks a signed founder agreement required by institutional investors.
• Revenue: Zero dollars; the product is in the pilot phase with two hospitals.

Operational Facts

• Development Timeline: David worked solo for 6 months on market research and conceptualization before recruiting Sarah and Mark.
• Product Status: Mark developed the Minimum Viable Product (MVP) over 4 months. Sarah secured two pilot agreements within 60 days of joining.
• Roles: David serves as CEO; Sarah as COO; Mark as CTO.
• Legal Structure: Currently operating as a Delaware C-Corp, but shares have not been formally issued.

Stakeholder Positions

• David (CEO): Proposes a 50/25/25 split. Argues that his initial capital, 6-month lead time, and original IP justify a controlling interest.
• Sarah (COO): Demands an equal 33.3 percent split. Argues her industry connections are the sole reason for the current pilots and future revenue.
• Mark (CTO): Demands an equal 33.3 percent split. States the company has no value without the proprietary code he wrote. Threatens to leave if undervalued.
• Potential Investors: Have indicated that a messy cap table or lack of vesting schedules is a deal-breaker for the upcoming Seed round.

Information Gaps

• IP Assignment: The case does not specify if a formal Intellectual Property Assignment Agreement was signed by Mark during MVP development.
• Market Valuation: Current pre-money valuation remains speculative without a lead investor term sheet.
• Opportunity Cost: Specific salary sacrifices for each founder are not quantified.

2. Strategic Analysis: HealthCraft Equity and Governance

Core Strategic Question

• How can HealthCraft resolve the equity deadlock to create a stable, investor-ready cap table without demotivating key talent or losing the CEO's founding vision?

Structural Analysis

Applying the Founders Pie Calculator framework reveals a misalignment between perceived value and future necessity. David's contribution is historical (capital and concept), while Sarah and Mark represent future execution (growth and technology). The current deadlock creates a Pre-seed Structural Risk: the team is optimized for failure because the cap table reflects past ego rather than future incentives.

Strategic Options

Preliminary Recommendation

HealthCraft should adopt a 40/30/30 split combined with a 4-year vesting schedule and a 1-year cliff. This recognizes David's financial risk and early work while ensuring Sarah and Mark are incentivized for long-term execution. Most importantly, it signals to investors that the team can negotiate difficult trade-offs.

3. Operations and Implementation Planner

Critical Path

• Immediate (Days 1-7): Conduct a facilitated mediation session to finalize the 40/30/30 split. Failure to agree here necessitates a wind-down.
• Short-term (Days 8-21): Formalize the Restricted Stock Purchase Agreements (RSPAs) with 4-year vesting and a 1-year cliff.
• Legal (Days 22-30): Execute IP Assignment Agreements for all code and market research produced to date.
• Investor Readiness (Days 31-60): Finalize the Seed Round pitch deck with a clean, unified cap table.

Key Constraints

• Founder Liquidity: David has already spent 50,000 dollars. His personal financial pressure may drive irrational negotiation tactics.
• Technical Dependency: Mark owns the MVP knowledge. If he exits before the IP assignment, the company is effectively insolvent.

Risk-Adjusted Implementation Strategy

The strategy assumes David will accept 40 percent in exchange for a Board Seat and CEO Super-voting Rights on specific items (e.g., sale of the company). This protects his vision while ceding economic equity. If Sarah or Mark refuse the 30 percent, the CEO must be prepared to replace one of them immediately using the remaining equity pool to attract a late-stage co-founder.

4. Senior Partner and Executive Review

BLUF

HealthCraft must finalize a 40/30/30 equity split within 14 days or cease operations. The current deadlock is a terminal defect. David's 50,000 dollar investment and six-month lead justify a 10 percent premium, but his demand for 50 percent ignores the replacement cost of a CTO and COO in a competitive health-tech market. Investors fund teams, not ideas. A fractured founding team is uninvestable.

Dangerous Assumption

The analysis assumes that David, Sarah, and Mark are all equally competent in their roles. If Sarah's pilot success is an anomaly or Mark's code is not scalable, the 30 percent allocations will become expensive dead weight on the cap table that requires future recapitalization.

Unaddressed Risks

• Tax Implications (High Consequence): Issuing shares now, after pilots are secured, may trigger a tax event if the internal valuation has risen above par value.
• Founder Divorce (High Probability): The interpersonal friction during this negotiation suggests a high likelihood of one founder leaving within 18 months, making the cliff and vesting terms the most critical part of the agreement.

Unconsidered Alternative

Convert David's 50,000 dollar contribution into a Convertible Note rather than equity. This treats his cash as debt that converts at the Seed round, allowing the equity split to remain a clean 33/33/33 while still compensating him for his financial risk and early lead time.

Verdict

APPROVED FOR LEADERSHIP REVIEW